Alto Ingredients, Inc. ALTO
3.73
(0.01)
(0.27%)
as of 25 Sep
- Market cap
- $290.1M
- P/E
- 5.5×
Follow ALTO
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
8.38 | 12.74 | 16.94 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.46 | 0.40 | 0.23 | 0.09 | |
P/FCF ratio |
8.63 | 11.79 | 24.81 | 0.00 | |
P/Operating CF |
15.13 | 86.00 | 22.49 | 3.54 | |
P/B ratio |
1.66 | 1.45 | 0.88 | 0.36 | |
Price to Tangible BV |
1.71 | 1.49 | 0.90 | 0.38 | |
EV/Sales |
0.51 | 0.46 | 0.29 | 0.16 | |
EV/EBITDA |
7.64 | 9.18 | 7.79 | 0.00 | |
EV/Operating CF |
7.38 | 11.83 | 20.23 | (24.43) | |
EV/FCF |
9.61 | 13.75 | 30.99 | (14.85) | |
Quick Ratio |
1.91 | 2.14 | 1.38 | 2.16 | |
Current Ratio |
3.19 | 3.81 | 2.64 | 3.56 | |
Net Debt/EBITDA |
2.08 | 4.67 | 3.74 | 2.69 | |
Debt/Assets |
15.23% | 18.91% | 20.48% | 25.90% | |
Debt/Equity |
0.23 | 0.29 | 0.32 | 0.45 | |
Asset Turnover |
2.39 | 2.32 | 2.32 | 2.29 | |
Operating CF/Net income |
2.50 | 1.06 | 0.44 | 1.64 | |
Capex/Depreciation |
(1.53) | (0.13) | (0.29) | (0.24) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.26% | 2.98% | 2.96% | 2.70% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.33% | 0.31% | 0.36% | 0.29% | |
Graham Net Nets |
0.05 | 0.06 | 0.06 | (0.19) | |
Graham Number |
7.25 | 5.34 | 3.55 | 0.00 | |
Earnings Yield |
11.93% | 7.85% | 5.90% | (63.89%) | |
Free Cash Flow Yield |
11.59% | 8.48% | 4.03% | (12.40%) | |
Revenue per Share |
3.25 | 3.00 | 3.11 | 3.22 | |
Operating CF per Share |
0.38 | 0.06 | 0.13 | 0.30 | |
Capex per Share |
(0.14) | (0.01) | (0.03) | (0.02) | |
Free Cash Flow per Share |
0.24 | 0.04 | 0.10 | 0.28 | |
Cash per Share |
0.37 | 0.39 | 0.35 | 0.49 | |
Shareholders Equity per Share |
3.44 | 3.34 | 3.29 | 2.97 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.44 | 3.34 | 3.29 | 2.97 | |
Free Cash Flow |
17.90 | 3.30 | 7.59 | 21.15 | |
Working Capital |
110.43 | 116.90 | 96.85 | 108.50 | |
Capital Expenditures |
(10.58) | (0.91) | (1.95) | (1.63) | |
Net Current Asset Value |
23.63 | 22.14 | 12.37 | (15.15) | |
EV/EBIT |
13.47 | 22.36 | 36.40 | 0.00 | |
Capex to Sales |
0.04 | 0.00 | 0.01 | 0.01 | |
Net Profit Margin |
4.63% | 1.76% | 9.26% | 5.76% | |
Price to Operating Income |
12.10 | 19.17 | 29.15 | 0.00 | |
| Other line items | |||||
Average Receivables |
62.67 | 62.58 | 56.64 | 53.40 | |
Average Payables |
19.96 | 18.17 | 17.44 | 16.36 | |
Average Inventory |
52.74 | 51.72 | 55.80 | 50.70 | |
Average Assets |
395.07 | 394.25 | 395.11 | 402.94 | |
Average Common Equity |
233.86 | 231.90 | 235.15 | 243.16 |
Columns are period end dates